• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
73,524.26 -719.08
( -0.97%)
Global Indices
Nasdaq
51,098.17 -484.76
(-0.94%)
Dow Jones
7,440.28 -165.03
(-2.17%)
Hang Seng
63,697.20 -2,890.92
(-4.34%)
Nikkei 225
10,374.30 13.98
(0.13%)
Forex
USD-INR
95.73 0.01
(0.01%)
EUR-INR
111.21 0.07
(0.06%)
GBP-INR
128.58 -0.06
(-0.05%)
JPY-INR
0.60 0.00
(0.01%)

EQUITY - MARKET SCREENER

Bafna Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
532989
INE878I01022
40.6429546
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BAFNAPH
38.11
422.86
EPS(TTM)
Face Value()
Div & Yield %
4.69
10
0
 
( Cr)
ParticularsMar 2026 ( Cr)Dec 2025 ( Cr)Sep 2025 ( Cr)
Gross Sales42.2438.2935.47
Other Operating Income0.000.000.00
Other Income 1.761.221.18
Total Income44.0039.5136.65
Total Expenditure 38.6935.2431.19
PBIDT5.314.275.46
Interest 1.030.860.86
PBDT4.283.414.60
Depreciation1.661.571.47
Tax-0.130.000.00
Fringe Benefit Tax0.000.000.00
Deferred Tax0.000.000.00
Reported Profit After Tax2.751.843.12
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item2.751.843.12
EPS (Unit Curr.)1.160.781.32
EPS (Adj) (Unit Curr.)1.160.781.32
Calculated EPS (Unit Curr.)1.160.781.32
Calculated EPS (Adj) (Unit Curr.)1.160.781.32
Calculated EPS (Ann.) (Unit Curr.)4.653.115.28
Calculated EPS (Adj) (Ann.) (Unit Curr.)4.653.115.28
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity23.6623.6623.66
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)12.5711.1515.39
PBDTM(%)10.138.9112.97
PATM(%)6.514.818.80